{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:38:14Z","timestamp":1761662294831},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"s5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CLIN INFECT DIS"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1086\/431673","type":"journal-article","created":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T12:13:16Z","timestamp":1123243996000},"page":"S315-S332","source":"Crossref","is-referenced-by-count":106,"title":["In Vitro Activity of Tigecycline against Isolates from Patients Enrolled in Phase 3 Clinical Trials of Treatment for Complicated Skin and Skin\u2010Structure Infections and Complicated Intra\u2010Abdominal Infections"],"prefix":"10.1093","volume":"41","author":[{"given":"Patricia\u00a0A.","family":"Bradford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.\u00a0Tasha","family":"Weaver\u2010Sands","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter\u00a0J.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"rf1_175","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(99)00216-4"},{"key":"rf2_176","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh125"},{"key":"rf3_177","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.43.4.738","volume":"43","author":"Petersen PJ","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"rf4_178","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinmicnews.2004.10.001"},{"key":"rf5_179","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.9.2604-2608.2001"},{"key":"rf6_180","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(00)00198-9"},{"key":"rf7_181","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.10.3164-3167.2002"},{"key":"rf10_182","unstructured":"Rose G, Loh E. Efficacy and safety of tigecycline compared with vancomycin\/aztreonam in patients with complicated skin and skin structure infections: results from a phase 3, randomized, double-blind trial [control no. TH-13]. In: Program and abstracts of the 11th Annual International Symposium on Staphylococci and Staphylococcal Infections (Charleston, SC). International Society on Staphylococci and Staphylococcal Infections, 2004."},{"key":"rf11_183","unstructured":"Ellis-Grosse EJ, Loh E. Tigecycline compared with imipenem\/cilastatin in the treatment of complicated intra-abdominal infections [poster P1317]. In: Program and abstracts of the 15th European Congress of Clinical Microbiology and Infectious Diseases (Copenhagen). Basel: European Society of Clinical Microbiology and Infectious Diseases, 2005."},{"key":"rf12_184","unstructured":"Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 15th informational supplement. [CLSI document M100-S15]. Vol 25. Wayne, PA: Clinical Laboratory Standards Institute, 2005."},{"key":"rf13_185","unstructured":"National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard. 6th ed. [NCCLS document M11-A6]. Vol 24. Wayne, PA: National Committee for Clinical Laboratory Standards, 2004."},{"key":"rf14_186","unstructured":"National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. 6th ed. [NCCLS document M7-A6]. Vol 23. Wayne, PA: National Committee for Clinical Laboratory Standards, 2003."},{"key":"rf15_187","doi-asserted-by":"publisher","DOI":"10.1016\/0924-8579(96)00004-0"},{"key":"rf16_188","first-page":"1037","author":"Swartz MN","year":"2000","journal-title":"Philadelphia: Churchill Livingstone"},{"key":"rf17_189","first-page":"821","author":"Levison ME","year":"2000","journal-title":"Philadelphia: Churchill Livingstone"},{"key":"rf18_190","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.3.1017-1022.2005"},{"key":"rf19_191","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.665-669.2003"},{"key":"rf20_192","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.2.791-793.2005"},{"key":"rf21_193","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.972-978.2003"},{"key":"rf22_194","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-0691.2000.00034-6.x"},{"key":"rf23_195","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.10.2747-2751.2000"},{"key":"rf24_196","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.1034-1036.2004"},{"key":"rf25_197","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(99)00092-9"},{"key":"rf26_198","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.400-404.2003"},{"key":"rf27_199","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.03.002"},{"key":"rf28_200","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2004.08.007"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/41\/Supplement_5\/S315\/815598\/41-Supplement_5-S315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T17:42:37Z","timestamp":1552412557000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1086\/431673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":26,"journal-issue":{"issue":"s5","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["10.1086\/431673"],"URL":"https:\/\/doi.org\/10.1086\/431673","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}